Leidschendam, Netherlands

Floris De Steenwinkel


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 44(Granted Patents)


Company Filing History:


Years Active: 1981

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Floris De Steenwinkel

Introduction

Floris De Steenwinkel is a notable inventor based in Leidschendam, Netherlands. He has made significant contributions to the field of immunoassays, particularly through his innovative patent that addresses the detection of antigens and antibodies. His work is essential in the medical field, especially for diagnosing various conditions.

Latest Patents

Floris De Steenwinkel holds a patent for an immunoassay involving agglutination. This particle agglutination assay is designed for detecting antigens, antibodies, and other binding proteins, such as rheumatoid factor. The method utilizes two different particulate reagents, where the first reagent binds with the target antigen or antibody. Subsequently, a second reagent is added, which binds only to the first reagent particles that have already attached to the target. This process results in agglutination, allowing for the quantification of the antigen or antibody present. The assay is particularly valuable for identifying small quantities of antibodies in human sera, which can indicate allergies, infections, or autoimmune diseases.

Career Highlights

Floris De Steenwinkel is associated with Technicon Instruments Corporation, where he has applied his expertise in developing innovative diagnostic tools. His work has contributed to advancements in medical diagnostics, enhancing the ability to detect and quantify various immunological markers.

Collaborations

Throughout his career, Floris has collaborated with notable colleagues, including Pierre L Masson and Cesar L Cambiaso. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Floris De Steenwinkel's contributions to the field of immunoassays exemplify the impact of innovative thinking in medical diagnostics. His patent for a particle agglutination assay represents a significant advancement in the detection of antibodies and antigens, showcasing the importance of his work in improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…